Palo Alto Investors LP - SUNESIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Palo Alto Investors LP ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$3,820,000
+1.4%
6,974,8540.0%0.29%
-1.0%
Q1 2016$3,766,000
-39.8%
6,974,8540.0%0.29%
-16.1%
Q4 2015$6,260,000
+10.8%
6,974,8540.0%0.35%
+27.9%
Q3 2015$5,650,000
+107.1%
6,974,854
+669.6%
0.27%
+124.8%
Q2 2015$2,728,000
+84.6%
906,263
+50.2%
0.12%
+65.8%
Q1 2015$1,478,000603,4000.07%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 8,250,000$7,404,0003.11%
BVF INC/IL 4,777,381$4,288,0000.73%
NEA Management Company, LLC 7,789,644$7,011,0000.45%
Palo Alto Investors LP 6,974,854$6,260,0000.35%
Healthcare Value Capital, LLC 150,000$135,0000.22%
Frontier Wealth Management LLC 527,870$474,0000.08%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,067,122$1,855,0000.06%
Baker Brothers Advisors 4,450,000$3,994,0000.03%
Noven Financial Group, Inc. 41,000$37,0000.03%
FRANKLIN STREET ADVISORS INC /NC 100,000$90,0000.02%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders